A Danish company is spending $145 million upfront for certain rights to the first-ever needle-free adrenaline nasal spray for severe allergic reactions, unlocking sales potential …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Compared to other mammals, human children are dependent on their caregivers for a remarkably long time. Throughout the ages, they have developed “psychological tactics” to
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter
Verano Announces Third Quarter 2023 Financial Results Delivers Record Revenue of $240 Million, Increasing Net Cash Provided by Operating Activities, and Raises and Tightens 2023